Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus

Jorge Lujan-Zilbermann, Meredith G. Warshaw, Paige L. Williams, Stephen A. Spector, Michael D. Decker, Mark J. Abzug, Barb Heckman, Adam Manzella, Bill Kabat, Patrick Jean-Philippe, Sharon Nachman, George K. Siberry

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus'. Together they form a unique fingerprint.

Medicine & Life Sciences